TNFa

TNFa

TNFa related products

Structure Cat No. Product Name CAS No. Product Description
V40963 (Rac)-Benpyrine 1333714-43-4 Rac)-Benpyrine, the racemic mixture of Benpyrine, is a potent and orally bioactive TNF-α inhibitor with the potential for TNF-α mediated inflammatory and autoimmune disease research.
V6027 (S)-Tipifarnib 192185-71-0 Tipifarnib S enantiomer is the S-enantiomer of Tipifarnib, which is a highly efficient and specific inhibitor of farnesyltransferase with IC50 of 0.6 nM.
V6003 AX-024 HCl 1704801-24-0 AX-024 is a novel, potent andorally bioavailable inhibitor of the TCR-Nck interaction that selectively inhibits TCR-triggered T cell activation (IC50 1 nM).
V12729 Bioymifi 1420071-30-2 Bioymifi is an DR5 activator (Kd = 1.2 µM; IC50 = 2 µM).
V30065 Hispidol 5786-54-9 Hispidol ((Z)-Hispidol) is a potential therapeutic for inflammatory bowel disease; inhibits TNF-α induced adhesion of monocytes to colon epithelial cells with an IC50 of 0.50 µM.
V32271 Homoplantaginin 17680-84-1 Homoplantaginin is a naturally occurring flavonoid isolatedfrom Salvia plebeia (a traditional Chinese medicine), exhibits anti-inflammatory and antioxidant activity by inhibitingTNF-α, IL-6mRNA expression, andIKKβandNF-κBphosphorylation.
V10414 Hypaconitine 6900-87-4 Hypaconitine is a highly toxic natural active ingredient extracted from the genus Aconitum and is widely utilized in study/research of rheumatic diseases.
V23299 KR-33494 1021497-97-1 KR-33493 is a potent inhibitor of Fas-mediated cell death (FAF1).
V3781 LY303511 HCl 2070014-90-1 LY303511 is an analog ofLY294002and is also known as NV-128 and EM 101.
V31112 Mesaconitine 2752-64-9 Mesaconitine is the main active ingredient of Aconitum plants and has a variety of pharmaceutical effects.
V0037 Necrostatin-1 (Nec-1) 4311-88-0 Necrostatin-1 (Nec-1) is a novel, potent and specific RIP1 (receptor-interacting protein 1) kinase inhibitor that inhibits TNF-α-induced necroptosis with EC50 of 490 nM in 293T cells.
V0035 Pomalidomide (CC4047 or actimid) 19171-19-8 Pomalidomide (formerly also known as CC-4047 or actimid), an analog of thalidomide, is a potent andorally bioavailable immunomodulatory molecule with antineoplastic activity.
V0038 QNZ (EVP4593; CAY10470) 545380-34-5 QNZ (also known as EVP-4593 or CAY-10470),a quinazoline derivative, is a novel and potentNF-κB inhibitor, which shows potent inhibitory activity toward both NF-κB activation and TNF-α production with IC50 of 11 nM and 7 nM in human Jurkat T cells, respectively.
V13563 R-7050 303997-35-5 R-7050 (R7050) is a novel, potent and selective tumor necrosis factor/TNF-α receptor antagonist acting by blocking receptor-adaptor molecule complex formation and subsequent receptor internalization, but not TNF-α ligand-receptor binding.
V13666 REN-1189(CPI-1189) 183619-38-7 CPI-1189 is a TNF-α release inhibitor (antagonist) with antioxidant and neuro-protective (neuro-protection) activities.
V14615 Semapimod tetrahydrochloride 164301-51-3 Semapimod 4HCl, thetetrahydrochloride salt ofSemapimod mesylate (AXD 455; AIDS-121302;CNI-1493), is a novel and potentcytokine inhibitor that inhibits the production of proinflammatory cytokines such asTNF-α, IL-1β, and IL-6.
V15104 SPD-304 869998-49-2 SPD-304 is a novel, potent and selective inhibitor of tumor necrosis factor α (TNFα) withan IC50 of 22 µM forpreventing binding to the TNF Receptor 1 (TNFR1).
V0036 Thalidomide (Immunoprin, Contergan and Thalomid) 50-35-1 Thalidomide (trade names Immunoprin, Contergan and Thalomid among others) is a potent immunomodulatory agent and a drug approved in the 1950s.
V40171 UCB-9260 1515888-53-5 UCB-9260 (UCB9260; UCB 9260) is an oral anti-inflammatory agent with the potential to treat autoimmune diseases such as rheumatoid arthritis and Crohns disease.
V15441 UTL-5g 646530-37-2 UTL-5g (GBL-5g) is an anti~inflammatory TNF-α inhibitor (antagonist) with chemoprotective and hepatoradioprotective effects.
Contact Us Back to top